Skip to Content
Merck
  • LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.

LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.

Movement disorders : official journal of the Movement Disorder Society (2009-08-13)
Zijuan Zhang, Jean-Marc Burgunder, Xingkai An, Yan Wu, Wenjun Chen, Jinhong Zhang, Yingcheng Wang, Yanming Xu, Yingru Gou, Guanggu Yuan, Xueye Mao, Rong Peng
ABSTRACT

Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2 (LRRK2), are associated with autosomal dominant and sporadic forms of Parkinson's disease (PD) and are the most common genetic causes of PD. Recently, a R1628P variant has been reported as a risk factor for PD in Taiwan and Singapore. To determine the association of this variant and PD in the Han-Chinese population from mainland China, we analyzed its frequency in a cohort of 600 patients and 459 unrelated healthy controls. Forty (6.7%) patients were heterozygous and 3 (0.5%) homozygous for the R1628P variant, which was significantly more frequent than in the controls [2.4% heterozygous and 0.0% homozygous, Odds ratio = 3.14, 95%CI: 1.60-6.17, P < 0.01]. Considering the age at onset, this difference was found only in late-onset PD (older than 50) [Odds ratio = 3.76, 95% CI: 1.90-7.45, P < 0.01]. Our data confirms that the LRRK2 R1628P variant is associated with an increased risk to develop late onset PD in the ethnic Han-Chinese population.